In-Depth Research On:
Repros Therapeutics Inc. (RPRX)

Sign Up Now to Download a Free Research Report on RPRX

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts

Select your areas of interest / would you like to receive the newsletter?




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Repros Therapeutics Inc.

Repros Therapeutics shares surged 15.77 percent to close at $17.91 a share Thursday. The stock traded between $16.64 and $19.09 on volume of 1.73 million shares traded. The company is on pace to submit a New Drug Application for Androxal before the end of 2014. Shares of Repros Therapeutics are down approximately 2.0 percent year-to-date.

Going forward ... (see research report)


RESEARCH REPORT ON RPRX
Download Free Report Now


Preview Pages of Actual Research Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on